Unknown

Dataset Information

0

Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.


ABSTRACT: Targeted protein degradation has arisen as a powerful strategy for drug discovery allowing the targeting of undruggable proteins for proteasomal degradation. This approach most often employs heterobifunctional degraders consisting of a protein-targeting ligand linked to an E3 ligase recruiter to ubiquitinate and mark proteins of interest for proteasomal degradation. One challenge with this approach, however, is that only a few E3 ligase recruiters currently exist for targeted protein degradation applications, despite the hundreds of known E3 ligases in the human genome. Here, we utilized activity-based protein profiling (ABPP)-based covalent ligand screening approaches to identify cysteine-reactive small-molecules that react with the E3 ubiquitin ligase RNF4 and provide chemical starting points for the design of RNF4-based degraders. The hit covalent ligand from this screen reacted with either of two zinc-coordinating cysteines in the RING domain, C132 and C135, with no effect on RNF4 activity. We further optimized the potency of this hit and incorporated this potential RNF4 recruiter into a bifunctional degrader linked to JQ1, an inhibitor of the BET family of bromodomain proteins. We demonstrate that the resulting compound CCW 28-3 is capable of degrading BRD4 in a proteasome- and RNF4-dependent manner. In this study, we have shown the feasibility of using chemoproteomics-enabled covalent ligand screening platforms to expand the scope of E3 ligase recruiters that can be exploited for targeted protein degradation applications.

SUBMITTER: Ward CC 

PROVIDER: S-EPMC7422721 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.

Ward Carl C CC   Kleinman Jordan I JI   Brittain Scott M SM   Lee Patrick S PS   Chung Clive Yik Sham CYS   Kim Kenneth K   Petri Yana Y   Thomas Jason R JR   Tallarico John A JA   McKenna Jeffrey M JM   Schirle Markus M   Nomura Daniel K DK  

ACS chemical biology 20190513 11


Targeted protein degradation has arisen as a powerful strategy for drug discovery allowing the targeting of undruggable proteins for proteasomal degradation. This approach most often employs heterobifunctional degraders consisting of a protein-targeting ligand linked to an E3 ligase recruiter to ubiquitinate and mark proteins of interest for proteasomal degradation. One challenge with this approach, however, is that only a few E3 ligase recruiters currently exist for targeted protein degradation  ...[more]

Similar Datasets

| S-EPMC8928484 | biostudies-literature
| S-EPMC8480205 | biostudies-literature
| S-EPMC3371408 | biostudies-literature
| S-EPMC10564737 | biostudies-literature
| S-EPMC9732910 | biostudies-literature
2020-11-01 | GSE156101 | GEO
| S-EPMC7710139 | biostudies-literature
| S-EPMC10614948 | biostudies-literature
| S-EPMC6383986 | biostudies-literature
| S-EPMC10398894 | biostudies-literature